Figure 4. Survival outcomes of... | American Society of Hematology

Figure 4.

Survival outcomes of epcoritamab vs odronextamab. (A) PFS; (B) OS.

Survival outcomes of epcoritamab vs odronextamab. (A) PFS; (B) OS.

This Feature Is Available To Subscribers Only

Sign In or Create an Account